({4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl}methyl)(methyl)amine dihydrochloride

Catalog No. :
ACIABT123
CAS No. :
1955531-39-1
Molecular Formula :
C10H19Cl2FN4O
Molecular Weight :
301.19

IUPAC Name:1-(4-fluoro-1-((5-methyl-1,2,4-oxadiazol-3-yl)methyl)pyrrolidin-2-yl)-N-methylmethanamine dihydrochloride

({4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl}methyl)(methyl)amine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$907.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name({4-fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl}methyl)(methyl)amine dihydrochloride
IUPAC Name1-(4-fluoro-1-((5-methyl-1,2,4-oxadiazol-3-yl)methyl)pyrrolidin-2-yl)-N-methylmethanamine dihydrochloride
MDL No.MFCD30180862
Molecular FormulaC10H19Cl2FN4O
Molecular Weight301.19
SMILESCNCC1N(CC2=NOC(C)=N2)CC(F)C1.[H]Cl.[H]Cl
InChI KeyIYIIHDNDRZRCNA-UHFFFAOYSA-N
Synonym1-[4-Fluoro-1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]pyrrolidin-2-yl]-N-methylmethanamine
CAS No.1955531-39-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIABT123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIABT123 route product structure diagram
    ACIABT1231955531-39-1
Inquiry

2. ACIABT123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIABT123 route product structure diagram
    ACIABT1231955531-39-1
Inquiry

Comments (0)